Plavix

Sanofi Fined $52.8 Million for Denigrating Plavix Copies

Sanofi Fined $52.8 Million for Denigrating Plavix Copies

Bloomberg

DOJ Investigating Sanofi Over Plavix Disclosure

DOJ Investigating Sanofi Over Plavix Disclosure

Motley Fool

Bristol-Myers Squibb: Investors Can Focus On The Future After Plavix

Bristol-Myers Squibb: Investors Can Focus On The Future After Plavix

Seeking Alpha

Bristol-Myers, Sanofi revamp Plavix sales alliance

Bristol-Myers, Sanofi revamp Plavix sales alliance

Yahoo/AP

Trading Merck Ahead of the Patent Cliff

Trading Merck Ahead of the Patent Cliff

Motley Fool

Mylan Waits Patiently at the Bottom of the Patent Cliff

Mylan Waits Patiently at the Bottom of the Patent Cliff

Motley Fool

Big Pharma betting billions in high-stakes hunt for the next Lipitor

Big Pharma betting billions in high-stakes hunt for the next Lipitor

Fierce Biotech

Lilly heart drug Effient fails to carve new niche

Lilly heart drug Effient fails to carve new niche

Reuters

TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients

TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients

Forbes

Co-pay coupons lifted Lipitor. Can they defend Diovan?

Co-pay coupons lifted Lipitor. Can they defend Diovan?

Fierce Pharma